Product
Supplier
Encyclopedia
Inquiry
Home > Chemical Reagents > Organic Reagents > Retatrutide for Sale > GHK-CU AHK glutathione Tirzepatide
GHK-CU AHK glutathione Tirzepatide buy - large image1
GHK-CU AHK glutathione Tirzepatide buy - image1
GHK-CU AHK glutathione Tirzepatide buy - image2
GHK-CU AHK glutathione Tirzepatide buy - image3
GHK-CU AHK glutathione Tirzepatide buy - image4
GHK-CU AHK glutathione Tirzepatide buy - image5
GHK-CU AHK glutathione Tirzepatide buy - image6

GHK-CU AHK glutathione Tirzepatide

7470 Inquiries

Unit Price:

$8-10/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Packaging:

10mg 15mg 20mg 30mg 40mg 50mg

Price valid (until):

2026-11-28

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,100% TT in advance
Average Lead Time:
10 days
Qualification:
Main Products:

peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


    Key Specifications/ Special Features:

    Peptide form: Freeze - dried powder

    Dosage: 2mg, 5mg, 10mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg vials

    Packaging: 10 vials/kit

    Sample order: Accepted

    Inventory status: We have our own factory in China and also a warehouse in the United States. There is sufficient inventory, and goods are available for shipping and sale.

    We also accept custom orders, including products with larger dosage specifications and bottle - cap advertisements. Delivery time: Usually 3 - 20 days

    Shipping methods: DHL, USPS, UPS, special line, act

    Shop GHK-CU AHK glutathione Tirzepatide-Detailed Image 1
    name peptide
    Purity 99%
    Color white/blue

    China supplier peptides powder peptides vials 5mg 10mg various peptides


    Peptide Form: Lyophilized Powder


    Peptide Package: 10 Vials per box


    Peptide Purity: 99%


    Peptide MOQ: 1 kit (10 vials)


    We offer various types of peptides,about the peptides,we can provide the good quality,the good price.


    Customers who have ordered our products(peptides)have had very good feedback.


    World wide relaible buyers can contact us about the peptides.


    Shop GHK-CU AHK glutathione Tirzepatide-Detailed Image 4 Shop GHK-CU AHK glutathione Tirzepatide-Detailed Image 5

    1. Quality


    Each batch of our products will undergo corresponding quality inspections to ensure that the purity is above 99% before it is put on the market for sale, and there are corresponding test reports for reference.


    2. Price


    We are a company combining industry and trade, and have been in the industry for 12 years, so we can provide competitive prices and high-quality products.


    3. Packaging


    We can package according to customer requirements and customize products.


    4. Transportation


    Door to door, we are responsible for door-to-door delivery, do not require you to have any customs clearance ability.


    5.After-sales service


    We guarantee the arrival of the goods. If the goods do not arrive due to force majeure, we will refund in full or reissue the goods for you.

    Shop GHK-CU AHK glutathione Tirzepatide-Detailed Image 6


    Shipping Information

    We have professional packaging and shipping servicesShop GHK-CU AHK glutathione Tirzepatide-Detailed Image 7


      Shipping Information  


    FOB Port China (Mainland)


    Main Export Markets


    Main Export Markets
    Asia , Australasia , Central/SouthAmerica , EasternEurope , MidEast/Africa , NorthAmerica , Western Europe
    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Organic Reagents

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Room 3293, No. 2 Yuan Yuan Road, Yangcun Street, Wuqing District, Tianjin City

    Payment Terms:

    TT against copy of documents,D/P,100% TT in advance

    Average lead Time:

    10 days

    Year of Establishment:

    2025

    Company Certificates
    • Tianjin Obos Cosmetics Co., LtdCOA COA

    Tianjin Aobos Cosmetics Co., Ltd

  • Inquiry History
    7470 Inquiries
    Country Product Purchase Quantity Date Posted
    Canada

    Retatrutide

    1 G Oct 26, 2026
    Switzerland

    Retatrutide

    1 KG Oct 26, 2026
    United States

    Retatrutide

    10 MG Oct 26, 2026
    Australia

    Retatrutide

    30 MG Oct 26, 2026
    United States

    Retatrutide

    30 MG Oct 26, 2026
    United States

    Tesa

    2 MG Oct 25, 2026
    Colombia

    Retatrutide

    15 MG Oct 25, 2026
    United States

    Retatrutide

    10 G Oct 25, 2026
    Canada

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    1 G Oct 25, 2026
    Netherlands

    Retatrutide

    10 MG Oct 25, 2026
    Australia

    Retatrutide

    10 MG Oct 25, 2026
    Netherlands

    Retatrutide

    20 MG Oct 25, 2026
    Germany

    Retatrutide

    1 KG Oct 25, 2026
    United Kingdom

    Retatrutide

    10 G Oct 25, 2026
    United States

    Retatrutide

    20 MG Oct 25, 2026
    Poland

    Retatrutide

    20 MG Oct 25, 2026
    United States

    Retatrutide

    10 MT Oct 25, 2026
    United States

    Retatrutide

    300 MG Oct 25, 2026
    Germany

    Retatrutide

    1 MT Oct 24, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.